EN
Home/Answers/Diarrhoea on GLP-1 medicines
ALLAll countries Side effects and safety

How do you stop diarrhoea on tirzepatide and semaglutide?

What we checked16 sources, each one opened and linked to the sentence it supportsLast checked Nov 16, 2026 · Next review due Nov 16, 2027 · How we write
The short answer

Drinking plenty, including oral rehydration solution, is the first step for diarrhoea on tirzepatide (Mounjaro, Zepbound) or semaglutide (Ozempic, Wegovy). The US labels say it mostly comes during dose increases. In Wegovy trials, a typical bout lasted 3 days. Prescribers can slow the dose increases, and loperamide can help for a short time.

How common is diarrhoea, and when does it start?

Diarrhoea is one of the most common side effects of both medicines, and most of it comes while the dose is still being stepped up.1,2

In the US Zepbound weight trials, 19% to 23% of people on tirzepatide had diarrhoea, against 8% on a dummy injection (placebo).1 In the US Wegovy weight trials, 30% on semaglutide 2.4 mg had it, against 16% on placebo.2

The US Zepbound label says most nausea, vomiting and diarrhoea came during the dose step-ups and decreased over time.1 The EU, UK, Australian and Canadian tirzepatide labels say the same, and the EU Wegovy label ties diarrhoea mainly to the step-ups.3,10,11,12,4

In 3 STEP trials of semaglutide 2.4 mg, a typical bout of diarrhoea lasted 3 days, about as long as on placebo.5 Diarrhoea was most common at about week 20, near the end of the step-ups, and fell after that.5 Novo Nordisk, which makes semaglutide, funded the trials.5 Diarrhoea made 0.7% of people on Wegovy stop for good, against 0.1% on placebo.2

What can you do to settle it?

Drinking enough comes first. The US labels report kidney injury after fluid loss from diarrhoea, in some cases needing dialysis.1,2

Both US labels say most of these kidney cases followed dehydration from nausea, vomiting or diarrhoea.1,2 The EU Wegovy label says people should take precautions to avoid losing fluid.4 The US Wegovy Medication Guide says drinking fluids helps reduce the chance of dehydration.2

The NHS advises lots of fluids, in small sips if you feel sick. It says fruit juice and fizzy drinks can make diarrhoea worse.6 Oral rehydration solution is a powder you mix with water, and it puts back the sugar, salts and minerals you lose.7 The NHS also says to eat when you feel able, and that avoiding fatty or spicy foods may help.6

If a dose is hard to tolerate, the US Wegovy label suggests waiting 4 more weeks before the next increase.2 The US Zepbound label suggests a lower maintenance dose.1 Diarrhoea has other causes too. The NHS says the most common are a stomach bug and food poisoning.6

Can you take loperamide or bismuth for it?

Loperamide can stop diarrhoea for a few hours, the NHS says.6 Its UK label says to stop it promptly if constipation or a swollen tummy develops.8

The UK Imodium Classic label gives 4 mg first, then 2 mg after each loose stool, up to 12 mg a day.8 It says not to use it when slowing the gut must be avoided, because of the risk of a blocked bowel (ileus).8 It also rules it out for diarrhoea with blood in the stool and a high fever. With no improvement in 48 hours, the label says to stop it.8

The EU Wegovy label lists blocked bowel, including ileus, from reports after launch.4 The UK Imodium label also says replacing lost fluid stays the priority.8

The US Pepto-Bismol (bismuth subsalicylate) label says not to use it with bloody or black stools, or for more than 2 days.9 It contains salicylate, the same family as aspirin, and can turn the stool and tongue dark.9 The label lists diabetes and blood-thinning medicines as ones to check with a doctor or pharmacist before use.9

What do people on GLP‑1 medicines report about diarrhoea?

From public patient forums: 654 Reddit threads in r/Zepbound, r/mounjarouk, r/Mounjaro, r/WegovyWeightLoss, r/Semaglutide and r/Ozempic, read from October 2025 to October 2026. Personal reports, not medical evidence.

What people describe

  • Matches the label Many say diarrhoea started or flared after a dose increase, then eased over the next few doses.1,3
  • Not studied Several describe a weekly pattern, with symptoms 1 to 3 days after the shot. We found no study that tracked diarrhoea by day after the injection.
  • Matches the NHS Several found or strongly suspected another cause, such as a stomach bug or food poisoning.6
  • Matches the label Several describe diarrhoea bad enough to need urgent care or fluids through a drip. The US labels report kidney injury after fluid loss from diarrhoea.1,2

Advice people share

  • Matches the label Many advise not stepping up while symptoms last, and asking the prescriber about holding the dose or going back to the previous one.2,4
  • Matches the NHS Many advise oral rehydration salts rather than plain water alone.7
  • Matches the label Many use loperamide for short spells, and some warn it can swing them into constipation. The UK Imodium label says to stop it promptly if constipation develops.8
  • Label says otherwise Several posts mention improvised doses, such as counting pen clicks or splitting the weekly dose. The labels give set doses, injected once a week.1,2

In your country

The tirzepatide labels and the US and EU Wegovy labels tie diarrhoea mainly to the dose step-ups;1,2,3,4 what differs is the brands sold and, for Wegovy, the wording on slowing down.

Australia

Sold as: Tirzepatide: Mounjaro. Semaglutide injection, weight: Wegovy. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: none (Wegovy pill treated as not approved). Semaglutide tablets, diabetes: Rybelsus approved; whether supplied not confirmed.

Label: For significant stomach symptoms, the Australian Wegovy Product Information says to consider delaying the next increase until symptoms improve, with no set number of weeks.14

Emergency number: 000

Side effects and risks in Australia

Canada

Sold as: Tirzepatide: Mounjaro, Mounjaro KwikPen, Zepbound. Semaglutide injection, weight: Wegovy. Semaglutide injection, diabetes: Ozempic; Semaglutide Injection (Dr. Reddy’s; shortage reported Jul 2026, lots recalled Aug 2026); Apo-Semaglutide (one lot recalled Aug 2026). Semaglutide tablets, weight: none (no oral Wegovy in Health Canada’s drug database). Semaglutide tablets, diabetes: Rybelsus. Semaglutide approved but not marketed: Sevmia, Poviztra, Plosbrio, Aspen-Semaglutide, Semaglutide Injection (Aspen), Sandoz Semaglutide.

Label: The Canadian Wegovy monograph, like the US label, suggests delaying the next increase by 4 weeks if a dose is not tolerated, so the answer above applies.15

Emergency number: 911

Side effects and risks in Canada

France

Sold as: Tirzepatide: Mounjaro. Semaglutide injection, weight: Wegovy. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: none (Wegovy pill not sold in France). Semaglutide tablets, diabetes: none found (Rybelsus not in France’s medicines database).

Label: For significant stomach symptoms, the EU Wegovy label says delaying the next increase or going back to the previous dose until symptoms improve could be considered, with no set number of weeks.4

Emergency number: 15 or 112

Side effects and risks in France

Germany

Sold as: Tirzepatide: Mounjaro. Semaglutide injection, weight: Wegovy, including 7.2 mg. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: Wegovy Tablette. Semaglutide tablets, diabetes: Rybelsus.

Label: For significant stomach symptoms, the EU Wegovy label says delaying the next increase or going back to the previous dose until symptoms improve could be considered, with no set number of weeks.4

Emergency number: 112

Side effects and risks in Germany

India

Sold as: Tirzepatide: Mounjaro, Yurpeak. Semaglutide injection, weight: Wegovy; Poviztra; Noveltreat. Semaglutide injection, diabetes: Ozempic; Obeda (Dr Reddy’s; recalled Jul 2026 over an active-ingredient impurity; on 23 Oct 2026 the company said it planned to relaunch in Nov; resumption not confirmed at 8 Nov 2026; distributors told Reuters it may be discontinued); Sematrinity; GLIPIQ; Semalix (batches recalled Jul 2026); Semanat; Semafull. Semaglutide injection, diabetes and weight: Semaglyn; Mashema; Alterme; Semasize; Obesema; Hepaglide. Semaglutide, diabetes and weight (form not confirmed): Obeda Pro; Obeda Plus (Dr Reddy’s, made by Hetero Labs; in the market from late Jul 2026). Semaglutide injection, use not confirmed: Semanext; Livarise; Sundae. Semaglutide, form and use not confirmed: Samakind; Usema (batches recalled). Semaglutide tablets, weight: not confirmed. Semaglutide tablets, diabetes: Rybelsus; Sembolic; Obeda (tablets not part of the Jul 2026 recall).

Label: We found no public Indian label to open, so it relies on the US, EU, UK, Australian and Canadian labels. The tirzepatide labels and the US and EU Wegovy labels tie diarrhoea mainly to the dose step-ups.1,2,3,4

Emergency number: 112

Side effects and risks in India

Saudi Arabia

Sold as: Tirzepatide: Mounjaro, Mounjaro KwikPen. Semaglutide injection, weight: Wegovy. Semaglutide injection, diabetes: Ozempic; Tasylev; Lugyda; Glucentra. Semaglutide tablets, weight: none (Wegovy pill not registered). Semaglutide tablets, diabetes: Rybelsus.

Label: We did not open a Saudi label for this page, so it relies on the US, EU, UK, Australian and Canadian labels. The tirzepatide labels and the US and EU Wegovy labels tie diarrhoea mainly to the dose step-ups.1,2,3,4

Emergency number: 997 or 911

Side effects and risks in Saudi Arabia

United Arab Emirates

Sold as: Tirzepatide: Mounjaro. Semaglutide injection, weight: Wegovy. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: Wegovy pill. Semaglutide tablets, diabetes: Rybelsus.

Label: We did not open a UAE label for this page, so it relies on the US, EU, UK, Australian and Canadian labels. The tirzepatide labels and the US and EU Wegovy labels tie diarrhoea mainly to the dose step-ups.1,2,3,4

Emergency number: 998 for an ambulance, or 999

Side effects and risks in the UAE

United Kingdom

Sold as: Tirzepatide: Mounjaro. Semaglutide injection, weight: Wegovy, including 7.2 mg. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: Wegovy tablets (authorised 11 Jun 2026; retail sale not confirmed). Semaglutide tablets, diabetes: Rybelsus.

Label: For significant stomach symptoms, the UK Wegovy SmPC says to consider delaying the next increase or going back to the previous dose until symptoms improve, with no set number of weeks.13

Emergency number: 999

Side effects and risks in the UK

United States

Sold as: Tirzepatide: Zepbound, Mounjaro. Semaglutide injection, weight: Wegovy, including Wegovy HD 7.2 mg. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: Wegovy pill. Semaglutide tablets, diabetes: Ozempic tablets; Rybelsus (being discontinued).

Label: The answer above applies.

Emergency number: 911

Side effects and risks in the US

Get help now: call your local emergency number for severe or persistent diarrhoea or vomiting, vomiting blood, any sudden or severe pain, or fainting, sudden dizziness or weakness.16 Emergency numbers: 911 in the US and Canada, 999 in the UK, 998 or 999 in the UAE, 000 in Australia, 112 in India and Germany, 15 or 112 in France, 997 or 911 in Saudi Arabia.

Contact your prescriber or a doctor right away if diarrhoea does not go away.2 The NHS also lists bloody diarrhoea, diarrhoea for more than 7 days, being unable to keep fluids down, dark yellow pee, peeing less than normal, or dizziness on standing that does not go away.6,7

Read the full picture

Related questions

Did this answer your question?

Sources

  1. Eli Lilly. Zepbound (tirzepatide) US prescribing information. Sections 2.1, 2.2, 5.3, 6.1. pi.lilly.com
  2. Novo Nordisk. Wegovy (semaglutide) US prescribing information and Medication Guide. Sections 2.2, 5.5, 6.1. novo-pi.com
  3. European Medicines Agency. Mounjaro summary of product characteristics (EU label), section 4.8. ema.europa.eu
  4. European Medicines Agency. Wegovy summary of product characteristics (EU label), sections 4.2, 4.4 and 4.8. ema.europa.eu
  5. Wharton S et al. Gastrointestinal tolerability of once-weekly semaglutide 2.4 mg in adults with overweight or obesity, and the relationship between gastrointestinal adverse events and weight loss. Diabetes Obes Metab 2022;24:94-105. STEP 1-4 trials funded by Novo Nordisk. PMC9293236
  6. NHS. Diarrhoea and vomiting. nhs.uk
  7. NHS. Dehydration. nhs.uk
  8. Imodium Classic 2 mg Capsules summary of product characteristics (UK label), sections 4.2 to 4.4. medicines.org.uk
  9. Pepto-Bismol (bismuth subsalicylate) chewable tablets, US Drug Facts label. dailymed.nlm.nih.gov
  10. Mounjaro KwikPen summary of product characteristics (UK label), section 4.8. medicines.org.uk
  11. Mounjaro Australian Product Information, section 4.8. medsinfo.com.au
  12. Zepbound (tirzepatide injection) Canadian Product Monograph. pdf.hres.ca
  13. Wegovy 2.4 mg FlexTouch summary of product characteristics (UK label), section 4.2. medicines.org.uk
  14. Wegovy Australian Product Information, section 4.2. medsinfo.com.au
  15. Wegovy (semaglutide injection) Canadian Product Monograph. pdf.hres.ca
  16. American College of Emergency Physicians. Know When to Go. emergencyphysicians.org

Last checked Nov 16, 2026 · Next review due Nov 16, 2027 · Report an error

How this answer was made. Written by the GLP Guidebook team from the sources above, all checked between Nov 9 and Nov 16, 2026. The “What people report” section summarises public patient forum posts we read; it is not medical evidence, and we never pass on advice that goes against the label. It’s general information, not medical advice. Talk to a doctor, pharmacist or other licensed prescriber before starting, stopping or changing any medicine. In an emergency, call your local emergency number. How we write